Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression

Fig. 6

Methylation of P4HA2 was correlated with prognosis in liver cancer from MethSurv. (A) Heat map of methylation levels of the P4HA2 methylated probe. Red to blue scale indicates high to low expression. Various colorful side-boxes were used to represent the event, age, race, ethnicity, UCSC_refGene_Group, and relation to UCSC_CpG_island. (B) DNA methylation forest of P4HA2. (C) Association of methylation at 5’UTR-N_Shelf-cg09830083 in P4HA2 with patient OS. (D) Association of methylation at TSS200; TSS1500-Island-cg11586658 in P4HA2 with patient OS. (E) Association of methylation at TSS200; TSS1500-Island-cg18640183 in P4HA2 with patient OS. (F) Association of methylation at 3’UTR-Open_Sea-cg26256836 in P4HA2 with patient OS.

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us